Quick Answer
Wave Life Sciences Ltd. reported R&D Expense of $182.78 million for fiscal year 2025.
Wave Life Sciences Ltd. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $182.78M | +14.5% |
| 2024 | $159.68M | +22.8% |
| 2023 | $130.01M | +12.2% |
| 2022 | $115.86M | -4.9% |
| 2021 | $121.88M | -6.9% |
| 2020 | $130.94M | -25.4% |
| 2019 | $175.43M | +30.5% |
| 2018 | $134.43M | +69.5% |
| 2017 | $79.31M | +94.3% |
| 2016 | $40.82M | +350.7% |
| 2015 | $9.06M | +278.2% |
| 2014 | $2.40M | +24.7% |
| 2013 | $1.92M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $45.87M | +11.4% | +5.5% |
| June 30, 2025 | $43.47M | +7.6% | +7.0% |
| March 31, 2025 | $40.62M | +21.5% | -1.4% |
| September 30, 2024 | $41.20M | +30.2% | +2.0% |
| June 30, 2024 | $40.39M | +21.2% | +20.8% |
| March 31, 2024 | $33.45M | +8.0% | +5.7% |
| September 30, 2023 | $31.64M | +14.7% | -5.0% |
| June 30, 2023 | $33.31M | +12.0% | +7.5% |
- Wave Life Sciences Ltd. showed an increase of +14.5% in R&D Expense compared to the prior fiscal year.
- Over the 2013–2025 period, Wave Life Sciences Ltd.’s r&d expense has grown by 9419.7% (from $1.92 million to $182.78 million).
- The most recent figure is from Wave Life Sciences Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: